

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neuron cell-cell adhesion (GO:0007158) | 6.54432978 |
| 2 | vocalization behavior (GO:0071625) | 5.98548770 |
| 3 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.26897925 |
| 4 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.22193002 |
| 5 | protein localization to synapse (GO:0035418) | 5.13083872 |
| 6 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.09951645 |
| 7 | neuron recognition (GO:0008038) | 4.91597437 |
| 8 | regulation of synapse structural plasticity (GO:0051823) | 4.90333830 |
| 9 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.88607426 |
| 10 | positive regulation of action potential (GO:0045760) | 4.83546583 |
| 11 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.74628868 |
| 12 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.58298065 |
| 13 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 4.54502058 |
| 14 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.53079068 |
| 15 | dendritic spine morphogenesis (GO:0060997) | 4.46122868 |
| 16 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 4.44599993 |
| 17 | axonal fasciculation (GO:0007413) | 4.40951088 |
| 18 | synaptic vesicle exocytosis (GO:0016079) | 4.38197244 |
| 19 | postsynaptic membrane organization (GO:0001941) | 4.36732520 |
| 20 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.26425561 |
| 21 | central nervous system projection neuron axonogenesis (GO:0021952) | 4.24269182 |
| 22 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.15819000 |
| 23 | locomotory exploration behavior (GO:0035641) | 4.14041752 |
| 24 | righting reflex (GO:0060013) | 4.11996432 |
| 25 | layer formation in cerebral cortex (GO:0021819) | 4.11869088 |
| 26 | response to pheromone (GO:0019236) | 4.11100499 |
| 27 | presynaptic membrane assembly (GO:0097105) | 4.10808659 |
| 28 | synaptic transmission, glutamatergic (GO:0035249) | 4.09888056 |
| 29 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.01640842 |
| 30 | startle response (GO:0001964) | 4.00517032 |
| 31 | neuron-neuron synaptic transmission (GO:0007270) | 3.98489617 |
| 32 | tachykinin receptor signaling pathway (GO:0007217) | 3.97251092 |
| 33 | neurotransmitter secretion (GO:0007269) | 3.96190202 |
| 34 | glutamate receptor signaling pathway (GO:0007215) | 3.95999680 |
| 35 | exploration behavior (GO:0035640) | 3.95874563 |
| 36 | negative regulation of dendrite development (GO:2000171) | 3.94499475 |
| 37 | glutamate secretion (GO:0014047) | 3.90762671 |
| 38 | positive regulation of synapse maturation (GO:0090129) | 3.89399014 |
| 39 | nucleobase catabolic process (GO:0046113) | 3.87051268 |
| 40 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.86426285 |
| 41 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.83962682 |
| 42 | establishment of mitochondrion localization (GO:0051654) | 3.80680890 |
| 43 | cell migration in hindbrain (GO:0021535) | 3.78253296 |
| 44 | drinking behavior (GO:0042756) | 3.78160917 |
| 45 | presynaptic membrane organization (GO:0097090) | 3.75013544 |
| 46 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.74924372 |
| 47 | positive regulation of synapse assembly (GO:0051965) | 3.74571233 |
| 48 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.72978549 |
| 49 | synaptic vesicle maturation (GO:0016188) | 3.69891171 |
| 50 | regulation of respiratory system process (GO:0044065) | 3.66269802 |
| 51 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.61542470 |
| 52 | behavioral fear response (GO:0001662) | 3.57673168 |
| 53 | behavioral defense response (GO:0002209) | 3.57673168 |
| 54 | dendrite morphogenesis (GO:0048813) | 3.54900820 |
| 55 | synapse assembly (GO:0007416) | 3.53926944 |
| 56 | glycosphingolipid biosynthetic process (GO:0006688) | 3.48599458 |
| 57 | regulation of action potential (GO:0098900) | 3.47737067 |
| 58 | gamma-aminobutyric acid transport (GO:0015812) | 3.47486511 |
| 59 | positive regulation of membrane potential (GO:0045838) | 3.47452027 |
| 60 | neuronal action potential propagation (GO:0019227) | 3.46831039 |
| 61 | regulation of postsynaptic membrane potential (GO:0060078) | 3.46547981 |
| 62 | regulation of synapse maturation (GO:0090128) | 3.44265817 |
| 63 | auditory behavior (GO:0031223) | 3.44110056 |
| 64 | transmission of nerve impulse (GO:0019226) | 3.41608860 |
| 65 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.41224552 |
| 66 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.39747239 |
| 67 | urinary tract smooth muscle contraction (GO:0014848) | 3.36725525 |
| 68 | regulation of synaptic vesicle transport (GO:1902803) | 3.35385624 |
| 69 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.31012694 |
| 70 | fear response (GO:0042596) | 3.27608286 |
| 71 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.27585093 |
| 72 | regulation of synapse assembly (GO:0051963) | 3.27583094 |
| 73 | behavioral response to cocaine (GO:0048148) | 3.27442026 |
| 74 | cerebellum development (GO:0021549) | 3.26776201 |
| 75 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.23183583 |
| 76 | regulation of synaptic transmission, GABAergic (GO:0032228) | 3.21575347 |
| 77 | central nervous system neuron axonogenesis (GO:0021955) | 3.21435776 |
| 78 | proline transport (GO:0015824) | 3.19390856 |
| 79 | membrane hyperpolarization (GO:0060081) | 3.19339346 |
| 80 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.19006877 |
| 81 | striatum development (GO:0021756) | 3.18639056 |
| 82 | neurotransmitter transport (GO:0006836) | 3.17993863 |
| 83 | regulation of synapse organization (GO:0050807) | 3.17831882 |
| 84 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.17525497 |
| 85 | regulation of respiratory gaseous exchange (GO:0043576) | 3.16251457 |
| 86 | response to auditory stimulus (GO:0010996) | 3.13131846 |
| 87 | learning (GO:0007612) | 3.11920137 |
| 88 | prepulse inhibition (GO:0060134) | 3.11376068 |
| 89 | limb bud formation (GO:0060174) | 3.08254472 |
| 90 | neuronal action potential (GO:0019228) | 3.07599842 |
| 91 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.06853976 |
| 92 | axon extension (GO:0048675) | 3.06307113 |
| 93 | adult walking behavior (GO:0007628) | 3.02999360 |
| 94 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.02929589 |
| 95 | positive regulation of neurotransmitter transport (GO:0051590) | 3.02418373 |
| 96 | positive regulation of amino acid transport (GO:0051957) | 3.01980616 |
| 97 | long-term memory (GO:0007616) | 3.01006740 |
| 98 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 3.00746931 |
| 99 | mitochondrion transport along microtubule (GO:0047497) | 3.00746931 |
| 100 | negative regulation of microtubule polymerization (GO:0031115) | 2.98947849 |
| 101 | mechanosensory behavior (GO:0007638) | 2.98476958 |
| 102 | synapse organization (GO:0050808) | 2.98381897 |
| 103 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.97673661 |
| 104 | dopamine receptor signaling pathway (GO:0007212) | 2.97294090 |
| 105 | negative regulation of axon extension (GO:0030517) | 2.97003336 |
| 106 | regulation of neurotransmitter levels (GO:0001505) | 2.96424161 |
| 107 | axon ensheathment in central nervous system (GO:0032291) | 2.95285549 |
| 108 | central nervous system myelination (GO:0022010) | 2.95285549 |
| 109 | positive regulation of dendritic spine development (GO:0060999) | 2.95259215 |
| 110 | cerebellar granule cell differentiation (GO:0021707) | 2.94939141 |
| 111 | membrane depolarization (GO:0051899) | 2.94257235 |
| 112 | regulation of neurotransmitter secretion (GO:0046928) | 2.93860172 |
| 113 | regulation of dopamine secretion (GO:0014059) | 2.93357986 |
| 114 | long-term synaptic potentiation (GO:0060291) | 2.91437955 |
| 115 | response to histamine (GO:0034776) | 2.90984760 |
| 116 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.89717481 |
| 117 | neuronal ion channel clustering (GO:0045161) | 2.89491004 |
| 118 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.88865971 |
| 119 | regulation of collateral sprouting (GO:0048670) | 2.85359653 |
| 120 | reflex (GO:0060004) | 2.83630121 |
| 121 | positive regulation of vascular permeability (GO:0043117) | 2.82301706 |
| 122 | membrane depolarization during action potential (GO:0086010) | 2.80587366 |
| 123 | neurofilament cytoskeleton organization (GO:0060052) | 2.74399461 |
| 124 | behavioral response to ethanol (GO:0048149) | 2.73826690 |
| 125 | behavioral response to nicotine (GO:0035095) | 2.67575104 |
| 126 | regulation of timing of cell differentiation (GO:0048505) | 2.67389841 |
| 127 | C4-dicarboxylate transport (GO:0015740) | 2.66645553 |
| 128 | inositol phosphate catabolic process (GO:0071545) | 2.63125822 |
| 129 | retinal cone cell development (GO:0046549) | 2.62275544 |
| 130 | regulation of development, heterochronic (GO:0040034) | 2.61838112 |
| 131 | retinal ganglion cell axon guidance (GO:0031290) | 2.61276504 |
| 132 | negative regulation of axonogenesis (GO:0050771) | 2.61077352 |
| 133 | positive regulation of digestive system process (GO:0060456) | 2.60308983 |
| 134 | regulation of vesicle fusion (GO:0031338) | 2.59432971 |
| 135 | negative regulation of synaptic transmission (GO:0050805) | 2.58560981 |
| 136 | regulation of axon guidance (GO:1902667) | 2.57842983 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.59415718 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.14970062 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.05144651 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.04353366 |
| 5 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.89049999 |
| 6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.85729001 |
| 7 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.76425309 |
| 8 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.60047715 |
| 9 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.57719329 |
| 10 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.57079530 |
| 11 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.55111331 |
| 12 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.51416419 |
| 13 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.51416419 |
| 14 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.50067025 |
| 15 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.42978243 |
| 16 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.42202473 |
| 17 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.40320660 |
| 18 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.36513173 |
| 19 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.29925676 |
| 20 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.29762193 |
| 21 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.28535146 |
| 22 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.26631090 |
| 23 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.19447307 |
| 24 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.17320481 |
| 25 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.12392167 |
| 26 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.09062431 |
| 27 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.08318438 |
| 28 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.97696948 |
| 29 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.95808771 |
| 30 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.95500138 |
| 31 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.92019000 |
| 32 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.90935036 |
| 33 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.83588784 |
| 34 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.83578910 |
| 35 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.80714524 |
| 36 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.78345618 |
| 37 | P300_19829295_ChIP-Seq_ESCs_Human | 1.65870948 |
| 38 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.65687021 |
| 39 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.65323581 |
| 40 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.64818019 |
| 41 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.62504629 |
| 42 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.59340955 |
| 43 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.59179686 |
| 44 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.54733024 |
| 45 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.50681305 |
| 46 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.41956063 |
| 47 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.40381641 |
| 48 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.39701016 |
| 49 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.39649576 |
| 50 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.38021380 |
| 51 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.36226041 |
| 52 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.35652094 |
| 53 | EWS_26573619_Chip-Seq_HEK293_Human | 1.34871833 |
| 54 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.34595309 |
| 55 | FUS_26573619_Chip-Seq_HEK293_Human | 1.32070012 |
| 56 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.31314527 |
| 57 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.30930282 |
| 58 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.29372141 |
| 59 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.28339861 |
| 60 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.27665848 |
| 61 | AR_25329375_ChIP-Seq_VCAP_Human | 1.26977527 |
| 62 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.24468859 |
| 63 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.23309666 |
| 64 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.23020280 |
| 65 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.23020280 |
| 66 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.22046379 |
| 67 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.21561667 |
| 68 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.20669559 |
| 69 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.19863366 |
| 70 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.19670079 |
| 71 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.19556651 |
| 72 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.18639536 |
| 73 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.17678030 |
| 74 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.16343187 |
| 75 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.14321018 |
| 76 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.14079660 |
| 77 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.12614763 |
| 78 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.12576491 |
| 79 | JUN_21703547_ChIP-Seq_K562_Human | 1.12575972 |
| 80 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.11806475 |
| 81 | STAT3_23295773_ChIP-Seq_U87_Human | 1.10088274 |
| 82 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.10014190 |
| 83 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.09867907 |
| 84 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.09671718 |
| 85 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.09063846 |
| 86 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.08541533 |
| 87 | TCF4_23295773_ChIP-Seq_U87_Human | 1.08528012 |
| 88 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.07908618 |
| 89 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.07904954 |
| 90 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.07820205 |
| 91 | VDR_22108803_ChIP-Seq_LS180_Human | 1.07279551 |
| 92 | AR_19668381_ChIP-Seq_PC3_Human | 1.06799164 |
| 93 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.06526627 |
| 94 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.04457104 |
| 95 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.03887595 |
| 96 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.02963573 |
| 97 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02681058 |
| 98 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.02428584 |
| 99 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.02296542 |
| 100 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.02122625 |
| 101 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02122625 |
| 102 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.01987632 |
| 103 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.01422932 |
| 104 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.98664662 |
| 105 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.98528462 |
| 106 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.97390034 |
| 107 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.96721954 |
| 108 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95860011 |
| 109 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.94956320 |
| 110 | KDM2B_26808549_Chip-Seq_REH_Human | 0.93278486 |
| 111 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.93273745 |
| 112 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.91501582 |
| 113 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.89856416 |
| 114 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.89464578 |
| 115 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.88169700 |
| 116 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.87990595 |
| 117 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.87377919 |
| 118 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.87324742 |
| 119 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.86341973 |
| 120 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.86288577 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 4.92052046 |
| 2 | MP0003880_abnormal_central_pattern | 4.28505333 |
| 3 | MP0002822_catalepsy | 3.93864383 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 3.65482233 |
| 5 | MP0004270_analgesia | 3.25608663 |
| 6 | MP0002063_abnormal_learning/memory/cond | 3.23262946 |
| 7 | MP0009745_abnormal_behavioral_response | 3.08626647 |
| 8 | MP0005423_abnormal_somatic_nervous | 2.88645207 |
| 9 | MP0002572_abnormal_emotion/affect_behav | 2.85451491 |
| 10 | MP0002064_seizures | 2.71725240 |
| 11 | MP0000778_abnormal_nervous_system | 2.67216065 |
| 12 | MP0001984_abnormal_olfaction | 2.65150559 |
| 13 | MP0001968_abnormal_touch/_nociception | 2.58847364 |
| 14 | MP0001486_abnormal_startle_reflex | 2.56531852 |
| 15 | MP0002734_abnormal_mechanical_nocicepti | 2.54065409 |
| 16 | MP0002735_abnormal_chemical_nociception | 2.51335412 |
| 17 | MP0006276_abnormal_autonomic_nervous | 2.48347053 |
| 18 | MP0002272_abnormal_nervous_system | 2.28769726 |
| 19 | MP0002736_abnormal_nociception_after | 2.27954101 |
| 20 | MP0009046_muscle_twitch | 2.22260932 |
| 21 | MP0002184_abnormal_innervation | 2.21908610 |
| 22 | MP0001529_abnormal_vocalization | 2.16910337 |
| 23 | MP0001501_abnormal_sleep_pattern | 2.01336481 |
| 24 | MP0002557_abnormal_social/conspecific_i | 2.00535407 |
| 25 | MP0001188_hyperpigmentation | 1.95773579 |
| 26 | MP0002067_abnormal_sensory_capabilities | 1.92227402 |
| 27 | MP0001440_abnormal_grooming_behavior | 1.89809622 |
| 28 | MP0002733_abnormal_thermal_nociception | 1.83348483 |
| 29 | MP0001970_abnormal_pain_threshold | 1.79426734 |
| 30 | MP0003121_genomic_imprinting | 1.75629739 |
| 31 | MP0005386_behavior/neurological_phenoty | 1.73788322 |
| 32 | MP0004924_abnormal_behavior | 1.73788322 |
| 33 | MP0000955_abnormal_spinal_cord | 1.73295270 |
| 34 | MP0004811_abnormal_neuron_physiology | 1.68554505 |
| 35 | MP0005645_abnormal_hypothalamus_physiol | 1.67240297 |
| 36 | MP0005646_abnormal_pituitary_gland | 1.63959582 |
| 37 | MP0003011_delayed_dark_adaptation | 1.53203821 |
| 38 | MP0002882_abnormal_neuron_morphology | 1.52154351 |
| 39 | MP0004858_abnormal_nervous_system | 1.44999771 |
| 40 | MP0005084_abnormal_gallbladder_morpholo | 1.42994673 |
| 41 | MP0006292_abnormal_olfactory_placode | 1.38199778 |
| 42 | MP0002066_abnormal_motor_capabilities/c | 1.35764808 |
| 43 | MP0010386_abnormal_urinary_bladder | 1.34177951 |
| 44 | MP0002909_abnormal_adrenal_gland | 1.34005686 |
| 45 | MP0004885_abnormal_endolymph | 1.33722129 |
| 46 | MP0005253_abnormal_eye_physiology | 1.31917148 |
| 47 | MP0004142_abnormal_muscle_tone | 1.28865997 |
| 48 | MP0009780_abnormal_chondrocyte_physiolo | 1.26944128 |
| 49 | MP0002152_abnormal_brain_morphology | 1.25694184 |
| 50 | MP0008569_lethality_at_weaning | 1.25550828 |
| 51 | MP0003879_abnormal_hair_cell | 1.23306165 |
| 52 | MP0000631_abnormal_neuroendocrine_gland | 1.22033473 |
| 53 | MP0003122_maternal_imprinting | 1.21389213 |
| 54 | MP0001502_abnormal_circadian_rhythm | 1.19776590 |
| 55 | MP0005499_abnormal_olfactory_system | 1.19238421 |
| 56 | MP0005394_taste/olfaction_phenotype | 1.19238421 |
| 57 | MP0001905_abnormal_dopamine_level | 1.19227311 |
| 58 | MP0002638_abnormal_pupillary_reflex | 1.18154914 |
| 59 | MP0004742_abnormal_vestibular_system | 1.17734982 |
| 60 | MP0005367_renal/urinary_system_phenotyp | 1.11975845 |
| 61 | MP0000516_abnormal_urinary_system | 1.11975845 |
| 62 | MP0002752_abnormal_somatic_nervous | 1.06300169 |
| 63 | MP0002837_dystrophic_cardiac_calcinosis | 1.05741732 |
| 64 | MP0002069_abnormal_eating/drinking_beha | 1.05603115 |
| 65 | MP0003329_amyloid_beta_deposits | 1.03248370 |
| 66 | MP0003787_abnormal_imprinting | 1.02547771 |
| 67 | MP0001177_atelectasis | 1.00919424 |
| 68 | MP0002102_abnormal_ear_morphology | 0.98649224 |
| 69 | MP0003861_abnormal_nervous_system | 0.97859886 |
| 70 | MP0005379_endocrine/exocrine_gland_phen | 0.97262815 |
| 71 | MP0004085_abnormal_heartbeat | 0.95960786 |
| 72 | MP0008789_abnormal_olfactory_epithelium | 0.95597144 |
| 73 | MP0000751_myopathy | 0.93850612 |
| 74 | MP0008877_abnormal_DNA_methylation | 0.93122054 |
| 75 | MP0001986_abnormal_taste_sensitivity | 0.93083902 |
| 76 | MP0005083_abnormal_biliary_tract | 0.90499984 |
| 77 | MP0003632_abnormal_nervous_system | 0.89025237 |
| 78 | MP0001963_abnormal_hearing_physiology | 0.88949267 |
| 79 | MP0002751_abnormal_autonomic_nervous | 0.88203827 |
| 80 | MP0005195_abnormal_posterior_eye | 0.88037172 |
| 81 | MP0008872_abnormal_physiological_respon | 0.87467568 |
| 82 | MP0000026_abnormal_inner_ear | 0.85917907 |
| 83 | MP0005551_abnormal_eye_electrophysiolog | 0.83942700 |
| 84 | MP0005409_darkened_coat_color | 0.83790597 |
| 85 | MP0000537_abnormal_urethra_morphology | 0.82969549 |
| 86 | MP0003890_abnormal_embryonic-extraembry | 0.81772632 |
| 87 | MP0003634_abnormal_glial_cell | 0.81765782 |
| 88 | MP0003137_abnormal_impulse_conducting | 0.80522315 |
| 89 | MP0003690_abnormal_glial_cell | 0.79854875 |
| 90 | MP0005085_abnormal_gallbladder_physiolo | 0.79500833 |
| 91 | MP0004133_heterotaxia | 0.78543917 |
| 92 | MP0003938_abnormal_ear_development | 0.76840214 |
| 93 | MP0003718_maternal_effect | 0.76396325 |
| 94 | MP0003195_calcinosis | 0.74882214 |
| 95 | MP0000569_abnormal_digit_pigmentation | 0.74158395 |
| 96 | MP0002876_abnormal_thyroid_physiology | 0.72842211 |
| 97 | MP0003119_abnormal_digestive_system | 0.72790568 |
| 98 | MP0003283_abnormal_digestive_organ | 0.72374674 |
| 99 | MP0005365_abnormal_bile_salt | 0.70713542 |
| 100 | MP0006072_abnormal_retinal_apoptosis | 0.70131087 |
| 101 | MP0002928_abnormal_bile_duct | 0.70121837 |
| 102 | MP0000639_abnormal_adrenal_gland | 0.70121254 |
| 103 | MP0002229_neurodegeneration | 0.68336471 |
| 104 | MP0010770_preweaning_lethality | 0.68180743 |
| 105 | MP0002082_postnatal_lethality | 0.68180743 |
| 106 | MP0000538_abnormal_urinary_bladder | 0.67897789 |
| 107 | MP0005187_abnormal_penis_morphology | 0.67789277 |
| 108 | MP0000920_abnormal_myelination | 0.67324816 |
| 109 | MP0003136_yellow_coat_color | 0.66796966 |
| 110 | MP0002234_abnormal_pharynx_morphology | 0.66666236 |
| 111 | MP0002653_abnormal_ependyma_morphology | 0.65715171 |
| 112 | MP0005171_absent_coat_pigmentation | 0.63343644 |
| 113 | MP0010769_abnormal_survival | 0.62719806 |
| 114 | MP0003631_nervous_system_phenotype | 0.61611014 |
| 115 | MP0003633_abnormal_nervous_system | 0.61548839 |
| 116 | MP0008961_abnormal_basal_metabolism | 0.61509929 |
| 117 | MP0000566_synostosis | 0.61335137 |
| 118 | MP0010768_mortality/aging | 0.59686860 |
| 119 | MP0001943_abnormal_respiration | 0.59563447 |
| 120 | MP0002081_perinatal_lethality | 0.58997998 |
| 121 | MP0003385_abnormal_body_wall | 0.57312740 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 6.31776946 |
| 2 | Myokymia (HP:0002411) | 4.95260589 |
| 3 | Hyperventilation (HP:0002883) | 4.56839008 |
| 4 | Focal seizures (HP:0007359) | 4.49173596 |
| 5 | Epileptic encephalopathy (HP:0200134) | 4.42467549 |
| 6 | Febrile seizures (HP:0002373) | 4.14170554 |
| 7 | Broad-based gait (HP:0002136) | 3.84264746 |
| 8 | Visual hallucinations (HP:0002367) | 3.71930524 |
| 9 | Atonic seizures (HP:0010819) | 3.31681342 |
| 10 | Protruding tongue (HP:0010808) | 3.28849486 |
| 11 | Oligodactyly (hands) (HP:0001180) | 3.21785527 |
| 12 | Progressive cerebellar ataxia (HP:0002073) | 3.20745243 |
| 13 | Amblyopia (HP:0000646) | 3.19791446 |
| 14 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.18108580 |
| 15 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.18108580 |
| 16 | Excessive salivation (HP:0003781) | 3.17780900 |
| 17 | Drooling (HP:0002307) | 3.17780900 |
| 18 | Shoulder girdle muscle weakness (HP:0003547) | 3.15838675 |
| 19 | Polyphagia (HP:0002591) | 3.14168084 |
| 20 | Poor eye contact (HP:0000817) | 3.01816601 |
| 21 | Generalized tonic-clonic seizures (HP:0002069) | 3.00293618 |
| 22 | Limb dystonia (HP:0002451) | 2.97140842 |
| 23 | Amyotrophic lateral sclerosis (HP:0007354) | 2.93927249 |
| 24 | Impaired social interactions (HP:0000735) | 2.89663651 |
| 25 | Abnormal social behavior (HP:0012433) | 2.89663651 |
| 26 | Lissencephaly (HP:0001339) | 2.89452783 |
| 27 | Hepatoblastoma (HP:0002884) | 2.88766623 |
| 28 | Absence seizures (HP:0002121) | 2.83434495 |
| 29 | Fetal akinesia sequence (HP:0001989) | 2.78053032 |
| 30 | Hypoplasia of the brainstem (HP:0002365) | 2.75235269 |
| 31 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.75235269 |
| 32 | Mutism (HP:0002300) | 2.75156495 |
| 33 | Gait imbalance (HP:0002141) | 2.73437658 |
| 34 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.73010112 |
| 35 | Termporal pattern (HP:0011008) | 2.71715075 |
| 36 | Insidious onset (HP:0003587) | 2.71715075 |
| 37 | Abnormal eating behavior (HP:0100738) | 2.68436913 |
| 38 | Absent speech (HP:0001344) | 2.66632859 |
| 39 | Morphological abnormality of the middle ear (HP:0008609) | 2.64921789 |
| 40 | Akinesia (HP:0002304) | 2.64745291 |
| 41 | Dialeptic seizures (HP:0011146) | 2.64669311 |
| 42 | Progressive inability to walk (HP:0002505) | 2.64651527 |
| 43 | Ankle clonus (HP:0011448) | 2.63595070 |
| 44 | Abnormality of the lower motor neuron (HP:0002366) | 2.62145430 |
| 45 | Epileptiform EEG discharges (HP:0011182) | 2.55285926 |
| 46 | Agitation (HP:0000713) | 2.50424460 |
| 47 | EEG with generalized epileptiform discharges (HP:0011198) | 2.49945094 |
| 48 | Hypsarrhythmia (HP:0002521) | 2.45814287 |
| 49 | Hypoventilation (HP:0002791) | 2.45715555 |
| 50 | Supranuclear gaze palsy (HP:0000605) | 2.35901287 |
| 51 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.31330180 |
| 52 | Abnormality of the corticospinal tract (HP:0002492) | 2.30808250 |
| 53 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.30788562 |
| 54 | Blue irides (HP:0000635) | 2.28604632 |
| 55 | Dysdiadochokinesis (HP:0002075) | 2.28071806 |
| 56 | Hypothermia (HP:0002045) | 2.27121774 |
| 57 | Hyperthyroidism (HP:0000836) | 2.26540538 |
| 58 | Anxiety (HP:0000739) | 2.25588411 |
| 59 | Failure to thrive in infancy (HP:0001531) | 2.23935684 |
| 60 | Gaze-evoked nystagmus (HP:0000640) | 2.23336025 |
| 61 | Exotropia (HP:0000577) | 2.23052152 |
| 62 | Urinary urgency (HP:0000012) | 2.23051553 |
| 63 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.21954303 |
| 64 | Inability to walk (HP:0002540) | 2.21219359 |
| 65 | Spastic gait (HP:0002064) | 2.20550020 |
| 66 | Abnormality of binocular vision (HP:0011514) | 2.18590364 |
| 67 | Diplopia (HP:0000651) | 2.18590364 |
| 68 | Action tremor (HP:0002345) | 2.17244120 |
| 69 | Truncal ataxia (HP:0002078) | 2.16916852 |
| 70 | Genetic anticipation (HP:0003743) | 2.16548918 |
| 71 | Esotropia (HP:0000565) | 2.14443629 |
| 72 | Intestinal atresia (HP:0011100) | 2.14182285 |
| 73 | Retinal dysplasia (HP:0007973) | 2.13931367 |
| 74 | Stereotypic behavior (HP:0000733) | 2.13138194 |
| 75 | Type II lissencephaly (HP:0007260) | 2.12828382 |
| 76 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.10321900 |
| 77 | Depression (HP:0000716) | 2.10251338 |
| 78 | Torticollis (HP:0000473) | 2.09879326 |
| 79 | Poor suck (HP:0002033) | 2.09814991 |
| 80 | Vitreoretinal degeneration (HP:0000655) | 2.07521705 |
| 81 | Inappropriate behavior (HP:0000719) | 2.06524213 |
| 82 | Abnormality of salivation (HP:0100755) | 2.05519122 |
| 83 | Sleep apnea (HP:0010535) | 2.05380253 |
| 84 | Hemiparesis (HP:0001269) | 2.04546583 |
| 85 | Specific learning disability (HP:0001328) | 2.02907076 |
| 86 | Sporadic (HP:0003745) | 2.00485701 |
| 87 | Neuronal loss in central nervous system (HP:0002529) | 2.00018210 |
| 88 | Abnormal hair whorl (HP:0010721) | 1.99399399 |
| 89 | Epidermoid cyst (HP:0200040) | 1.95876012 |
| 90 | True hermaphroditism (HP:0010459) | 1.95263734 |
| 91 | Congenital primary aphakia (HP:0007707) | 1.94973116 |
| 92 | Intention tremor (HP:0002080) | 1.94136749 |
| 93 | Medial flaring of the eyebrow (HP:0010747) | 1.93965685 |
| 94 | Pendular nystagmus (HP:0012043) | 1.93440990 |
| 95 | Congenital malformation of the right heart (HP:0011723) | 1.93129708 |
| 96 | Double outlet right ventricle (HP:0001719) | 1.93129708 |
| 97 | Muscular hypotonia of the trunk (HP:0008936) | 1.93094916 |
| 98 | Abnormality of midbrain morphology (HP:0002418) | 1.91725922 |
| 99 | Molar tooth sign on MRI (HP:0002419) | 1.91725922 |
| 100 | Hypoplasia of the corpus callosum (HP:0002079) | 1.91329736 |
| 101 | Autism (HP:0000717) | 1.89636311 |
| 102 | Spastic tetraplegia (HP:0002510) | 1.88549195 |
| 103 | Nephronophthisis (HP:0000090) | 1.88196949 |
| 104 | Lower limb muscle weakness (HP:0007340) | 1.86867285 |
| 105 | Nephrogenic diabetes insipidus (HP:0009806) | 1.86100530 |
| 106 | Oligodactyly (HP:0012165) | 1.85288959 |
| 107 | Abnormality of the pubic bones (HP:0003172) | 1.85078791 |
| 108 | Megalencephaly (HP:0001355) | 1.82011543 |
| 109 | Vaginal atresia (HP:0000148) | 1.81392079 |
| 110 | Focal dystonia (HP:0004373) | 1.81252545 |
| 111 | Anophthalmia (HP:0000528) | 1.80064655 |
| 112 | Cutaneous finger syndactyly (HP:0010554) | 1.79155088 |
| 113 | Pachygyria (HP:0001302) | 1.78324700 |
| 114 | Alacrima (HP:0000522) | 1.78127864 |
| 115 | Genital tract atresia (HP:0001827) | 1.77716843 |
| 116 | Obstructive sleep apnea (HP:0002870) | 1.77605389 |
| 117 | Pheochromocytoma (HP:0002666) | 1.77568301 |
| 118 | Incomplete penetrance (HP:0003829) | 1.77364210 |
| 119 | Neoplasm of the oral cavity (HP:0100649) | 1.76621653 |
| 120 | Renal hypoplasia (HP:0000089) | 1.76378321 |
| 121 | Decreased lacrimation (HP:0000633) | 1.75160627 |
| 122 | Optic nerve hypoplasia (HP:0000609) | 1.75019366 |
| 123 | Gastroesophageal reflux (HP:0002020) | 1.74703037 |
| 124 | Pancreatic cysts (HP:0001737) | 1.74586339 |
| 125 | Status epilepticus (HP:0002133) | 1.74336805 |
| 126 | Abolished electroretinogram (ERG) (HP:0000550) | 1.73071386 |
| 127 | Craniofacial dystonia (HP:0012179) | 1.72745787 |
| 128 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.72331588 |
| 129 | Neurofibrillary tangles (HP:0002185) | 1.72258513 |
| 130 | Truncus arteriosus (HP:0001660) | 1.70572474 |
| 131 | Cerebral inclusion bodies (HP:0100314) | 1.68427072 |
| 132 | Delayed gross motor development (HP:0002194) | 1.68017057 |
| 133 | Abnormality of the labia minora (HP:0012880) | 1.67909732 |
| 134 | Bradycardia (HP:0001662) | 1.65778018 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MARK1 | 5.34067841 |
| 2 | NTRK3 | 4.07168203 |
| 3 | CASK | 3.91656283 |
| 4 | EPHA4 | 3.08723979 |
| 5 | FRK | 2.62792513 |
| 6 | MAPK13 | 2.58808098 |
| 7 | NTRK2 | 2.57473938 |
| 8 | MAP3K4 | 2.26661360 |
| 9 | MINK1 | 2.22490313 |
| 10 | MAP4K2 | 2.19452034 |
| 11 | MAP2K7 | 2.15979772 |
| 12 | KSR1 | 2.14162988 |
| 13 | SIK3 | 2.11979035 |
| 14 | SIK2 | 2.11619990 |
| 15 | MAP3K12 | 2.00994322 |
| 16 | UHMK1 | 1.99105524 |
| 17 | TNIK | 1.97086717 |
| 18 | MAP3K9 | 1.88969011 |
| 19 | CAMKK1 | 1.82999811 |
| 20 | DYRK2 | 1.75339372 |
| 21 | PINK1 | 1.72208727 |
| 22 | DAPK2 | 1.59202012 |
| 23 | PHKG2 | 1.52936208 |
| 24 | PHKG1 | 1.52936208 |
| 25 | BCR | 1.39963981 |
| 26 | ERBB3 | 1.39688332 |
| 27 | FGFR2 | 1.38957736 |
| 28 | CDK5 | 1.38007306 |
| 29 | PLK2 | 1.37649603 |
| 30 | CAMKK2 | 1.32061047 |
| 31 | LIMK1 | 1.28910069 |
| 32 | TRIM28 | 1.26643568 |
| 33 | GRK5 | 1.26508766 |
| 34 | MAP2K4 | 1.26306495 |
| 35 | PAK6 | 1.24418887 |
| 36 | PNCK | 1.15959390 |
| 37 | PRPF4B | 1.14791635 |
| 38 | PRKCG | 1.10092491 |
| 39 | STK16 | 1.09940064 |
| 40 | ADRBK2 | 1.07144810 |
| 41 | DAPK1 | 1.05519187 |
| 42 | DYRK1A | 1.04139281 |
| 43 | SGK2 | 1.03573540 |
| 44 | SGK494 | 1.02025852 |
| 45 | SGK223 | 1.02025852 |
| 46 | EPHA3 | 1.00090998 |
| 47 | AKT3 | 0.97335600 |
| 48 | CSNK1G2 | 0.95527205 |
| 49 | CAMK2A | 0.95361300 |
| 50 | WNK3 | 0.94640664 |
| 51 | NTRK1 | 0.92337433 |
| 52 | IRAK2 | 0.92309274 |
| 53 | CAMK1G | 0.92151127 |
| 54 | PRKCE | 0.89569731 |
| 55 | EPHB2 | 0.86782522 |
| 56 | CSNK1A1L | 0.81820990 |
| 57 | KSR2 | 0.80257885 |
| 58 | CCNB1 | 0.78390238 |
| 59 | BMPR1B | 0.77973369 |
| 60 | CDK18 | 0.77484722 |
| 61 | MAP3K2 | 0.76092895 |
| 62 | INSRR | 0.74450074 |
| 63 | CAMK2B | 0.71890648 |
| 64 | MARK2 | 0.70885537 |
| 65 | SGK1 | 0.70213126 |
| 66 | FES | 0.70003162 |
| 67 | CDK14 | 0.69949491 |
| 68 | PRKCZ | 0.69507824 |
| 69 | PRKD3 | 0.69095631 |
| 70 | CDK15 | 0.68289484 |
| 71 | PKN1 | 0.67136203 |
| 72 | CAMK2D | 0.67068846 |
| 73 | ERBB4 | 0.65147736 |
| 74 | CSNK1G3 | 0.63819610 |
| 75 | PAK3 | 0.62014719 |
| 76 | RIPK4 | 0.61235638 |
| 77 | DYRK3 | 0.60953646 |
| 78 | GRK1 | 0.59028978 |
| 79 | CDK11A | 0.58961258 |
| 80 | TAOK1 | 0.58324113 |
| 81 | CDC42BPA | 0.57714989 |
| 82 | PRKCH | 0.57601304 |
| 83 | NME1 | 0.56819715 |
| 84 | WNK4 | 0.56512706 |
| 85 | CAMK1 | 0.55863188 |
| 86 | STK38L | 0.54552154 |
| 87 | SGK3 | 0.53772327 |
| 88 | PRKAA1 | 0.53589733 |
| 89 | ADRBK1 | 0.52175439 |
| 90 | BMPR2 | 0.52167835 |
| 91 | STK11 | 0.51749231 |
| 92 | RPS6KA2 | 0.51625630 |
| 93 | MAP2K1 | 0.50865309 |
| 94 | IRAK1 | 0.50520808 |
| 95 | FGR | 0.50206675 |
| 96 | CAMK4 | 0.49829417 |
| 97 | TYRO3 | 0.47928270 |
| 98 | CSNK1E | 0.45760398 |
| 99 | CAMK2G | 0.43812515 |
| 100 | CDK8 | 0.43512075 |
| 101 | OXSR1 | 0.42939624 |
| 102 | LATS2 | 0.42888746 |
| 103 | RET | 0.42466240 |
| 104 | PRKCB | 0.42256106 |
| 105 | MAP3K6 | 0.41331834 |
| 106 | ROCK1 | 0.40700287 |
| 107 | CAMK1D | 0.39758792 |
| 108 | RPS6KA3 | 0.39657002 |
| 109 | FER | 0.39608635 |
| 110 | YES1 | 0.39582934 |
| 111 | PRKACB | 0.39397267 |
| 112 | PTK2B | 0.38851466 |
| 113 | CSNK1G1 | 0.37892505 |
| 114 | MAPK9 | 0.37629441 |
| 115 | ERBB2 | 0.37581088 |
| 116 | CSNK1A1 | 0.37511334 |
| 117 | PRKACA | 0.37109608 |
| 118 | DYRK1B | 0.36458586 |
| 119 | RPS6KB1 | 0.35709542 |
| 120 | FYN | 0.35214530 |
| 121 | ROCK2 | 0.34120375 |
| 122 | STK39 | 0.33333777 |
| 123 | TNK2 | 0.33017920 |
| 124 | ICK | 0.32882899 |
| 125 | PRKACG | 0.31811691 |
| 126 | CSNK1D | 0.31638671 |
| 127 | CDK19 | 0.31342020 |
| 128 | GSK3B | 0.30010792 |
| 129 | PRKG1 | 0.29969486 |
| 130 | TAOK3 | 0.29312472 |
| 131 | CDK3 | 0.27708528 |
| 132 | MAPK10 | 0.26754265 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.22694239 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.39070398 |
| 3 | GABAergic synapse_Homo sapiens_hsa04727 | 2.90590594 |
| 4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.84814848 |
| 5 | Olfactory transduction_Homo sapiens_hsa04740 | 2.73054791 |
| 6 | Morphine addiction_Homo sapiens_hsa05032 | 2.65660281 |
| 7 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.65016114 |
| 8 | Circadian entrainment_Homo sapiens_hsa04713 | 2.51762454 |
| 9 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.39816469 |
| 10 | Taste transduction_Homo sapiens_hsa04742 | 2.34166236 |
| 11 | Long-term potentiation_Homo sapiens_hsa04720 | 2.28687656 |
| 12 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.27918290 |
| 13 | Axon guidance_Homo sapiens_hsa04360 | 2.11377581 |
| 14 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.08250578 |
| 15 | Cocaine addiction_Homo sapiens_hsa05030 | 2.07780619 |
| 16 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 2.05955791 |
| 17 | Cholinergic synapse_Homo sapiens_hsa04725 | 2.03801864 |
| 18 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.96528832 |
| 19 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.91695262 |
| 20 | Long-term depression_Homo sapiens_hsa04730 | 1.69330702 |
| 21 | Insulin secretion_Homo sapiens_hsa04911 | 1.68964248 |
| 22 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.65500531 |
| 23 | Renin secretion_Homo sapiens_hsa04924 | 1.61465430 |
| 24 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.59764222 |
| 25 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.54523702 |
| 26 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.48815074 |
| 27 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.48782686 |
| 28 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.46958371 |
| 29 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.44339392 |
| 30 | Salivary secretion_Homo sapiens_hsa04970 | 1.43115587 |
| 31 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.43044005 |
| 32 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.42629297 |
| 33 | Gap junction_Homo sapiens_hsa04540 | 1.40724329 |
| 34 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.35489778 |
| 35 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.32018873 |
| 36 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.31986293 |
| 37 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.20485022 |
| 38 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.14972766 |
| 39 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.12846920 |
| 40 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.11871421 |
| 41 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.10535692 |
| 42 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.09473489 |
| 43 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.08603186 |
| 44 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.01512059 |
| 45 | Phototransduction_Homo sapiens_hsa04744 | 0.98230350 |
| 46 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.98087101 |
| 47 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.97123498 |
| 48 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.96153218 |
| 49 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.94846254 |
| 50 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.93733564 |
| 51 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.93157631 |
| 52 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.92760560 |
| 53 | Melanogenesis_Homo sapiens_hsa04916 | 0.91015177 |
| 54 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.90297890 |
| 55 | Parkinsons disease_Homo sapiens_hsa05012 | 0.89821637 |
| 56 | Alzheimers disease_Homo sapiens_hsa05010 | 0.89309086 |
| 57 | ABC transporters_Homo sapiens_hsa02010 | 0.84468103 |
| 58 | Glioma_Homo sapiens_hsa05214 | 0.84208428 |
| 59 | Circadian rhythm_Homo sapiens_hsa04710 | 0.83188597 |
| 60 | Bile secretion_Homo sapiens_hsa04976 | 0.82497178 |
| 61 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.81163990 |
| 62 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.80322279 |
| 63 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.79528136 |
| 64 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.79067208 |
| 65 | Histidine metabolism_Homo sapiens_hsa00340 | 0.78596308 |
| 66 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.78471420 |
| 67 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.77128874 |
| 68 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.76572616 |
| 69 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.75669108 |
| 70 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.73726078 |
| 71 | Alcoholism_Homo sapiens_hsa05034 | 0.71826686 |
| 72 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.70222234 |
| 73 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.67339962 |
| 74 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.64961714 |
| 75 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.64911308 |
| 76 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.64217249 |
| 77 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.63588438 |
| 78 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.62515601 |
| 79 | Endometrial cancer_Homo sapiens_hsa05213 | 0.62448193 |
| 80 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.61713029 |
| 81 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.61181555 |
| 82 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.60900398 |
| 83 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.60852641 |
| 84 | Colorectal cancer_Homo sapiens_hsa05210 | 0.60790469 |
| 85 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.59868933 |
| 86 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.59199811 |
| 87 | Phagosome_Homo sapiens_hsa04145 | 0.58935761 |
| 88 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.58657505 |
| 89 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.56847719 |
| 90 | Huntingtons disease_Homo sapiens_hsa05016 | 0.55455398 |
| 91 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.54765926 |
| 92 | Protein export_Homo sapiens_hsa03060 | 0.54531643 |
| 93 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.53945037 |
| 94 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.53875268 |
| 95 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.53691149 |
| 96 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.52816070 |
| 97 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.50741974 |
| 98 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.50611413 |
| 99 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.50590221 |
| 100 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.50161046 |
| 101 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.49532727 |
| 102 | Retinol metabolism_Homo sapiens_hsa00830 | 0.48481668 |
| 103 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.46278447 |
| 104 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.45967425 |
| 105 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.45707149 |
| 106 | Basal transcription factors_Homo sapiens_hsa03022 | 0.43162554 |
| 107 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.42358839 |
| 108 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.42340757 |
| 109 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.41354224 |
| 110 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.40655553 |
| 111 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.40318191 |
| 112 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.40113349 |
| 113 | Prion diseases_Homo sapiens_hsa05020 | 0.38863656 |
| 114 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.38243405 |
| 115 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.37872541 |
| 116 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.35299863 |
| 117 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.34259260 |
| 118 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.32983402 |
| 119 | Melanoma_Homo sapiens_hsa05218 | 0.32723484 |
| 120 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.32557440 |
| 121 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.29583941 |
| 122 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.29528758 |
| 123 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.28726106 |
| 124 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.28324010 |
| 125 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.28054939 |
| 126 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.26986923 |
| 127 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.26691596 |
| 128 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.25045424 |
| 129 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.22731512 |
| 130 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.22486696 |
| 131 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.22271409 |
| 132 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.21891022 |
| 133 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.20864505 |

